TRIM8: a double-edged sword in glioblastoma with the power to heal or hurt

Glioblastoma multiforme (GBM) is an aggressive primary brain tumor and one of the most lethal central nervous system tumors in adults. Despite significant breakthroughs in standard treatment, only about 5% of patients survive 5 years or longer. Therefore, much effort has been put into the search for...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseinalizadeh, Hamed, Mohamadzadeh, Omid, Kahrizi, Mohammad Saeed, Razaghi Bahabadi, Zahra, Klionsky, Daniel J., Mirzei, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869596/
https://www.ncbi.nlm.nih.gov/pubmed/36690946
http://dx.doi.org/10.1186/s11658-023-00418-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9869596/
https://www.ncbi.nlm.nih.gov/pubmed/36690946
http://dx.doi.org/10.1186/s11658-023-00418-z

Ejemplares similares